EZZ Life Science Holdings Limited (ASX:EZZ) Insider Acquires A$246,149.30 in Stock

EZZ Life Science Holdings Limited (ASX:EZZ) insider Mark (Qizhou) Qin bought 90,830 shares of EZZ Life Science stock in a transaction dated Wednesday, December 11th. The stock was acquired at an average price of A$2.71 ($1.73) per share, with a total value of A$246,149.30 ($156,782.99).

EZZ Life Science Price Performance

The company has a debt-to-equity ratio of 0.58, a current ratio of 5.96 and a quick ratio of 4.53.

EZZ Life Science Increases Dividend

The business also recently declared a Final dividend, which was paid on Sunday, December 8th. Stockholders of record on Sunday, December 8th were issued a $0.02 dividend. This is a positive change from EZZ Life Science’s previous Final dividend of $0.01. This represents a dividend yield of 0.57%. The ex-dividend date was Monday, November 4th. EZZ Life Science’s dividend payout ratio (DPR) is presently 37.50%.

About EZZ Life Science

EZZ Life Science Holdings Limited engages in formulation, production, marketing, and sale of the health and wellbeing products in Australia, New Zealand, Mainland China, and internationally. The company operates in two segments, Brought in Lines and Company Owned Products. It is also involved in the wholesale distribution of the EAORON branded skin care products to retailers; and research and development, and sale of genomics and precision nutrition research products under the EZZ brand.